Climazolam
(Redirected from C18H13Cl2N3)
 | |
| Clinical data | |
|---|---|
| Trade names | Climasol |
| AHFS/Drugs.com | International Drug Names |
| ATCvet code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C18H13Cl2N3 |
| Molar mass | 342.22 g·mol−1 |
| 3D model (JSmol) | |
| |
Climazolam[1] (Ro21-3982) was introduced under licence as a veterinary medicine by the Swiss Pharmaceutical company Gräub under the tradename Climasol.[2] Climazolam is a benzodiazepine, specifically an imidazobenzodiazepine derivative developed by Hoffman-LaRoche. It is similar in structure to midazolam and diclazepam and is used in veterinary medicine for anesthetizing animals.[3][4]
References
[edit]- ^ US 4280957, Walser A, Fryer RI, "Imidazodiazepines and processes therefor", issued 28 July 1981, assigned to Hoffman La Roche
- ^ "Climazolam". Drugs.com. Archived from the original on 2017-08-01. Retrieved 2018-01-23.
- ^ Ganter M, Kanngiesser M (Aug 1991). "Effect of ketamine and its combinations with xylazine and climazolam on the circulation and respiration in swine". Zentralbl Veterinarmed A (in German). 38 (7): 501–509. doi:10.1111/j.1439-0442.1991.tb01041.x. PMID 1950241.
- ^ Bettschart-Wolfensberger R, Taylor PM, Sear JW, Bloomfield MR, Rentsch K, Dawling S (Oct 1996). "Physiologic effects of anesthesia induced and maintained by intravenous administration of a climazolam-ketamine combination in ponies premedicated with acepromazine and xylazine". American Journal of Veterinary Research. 57 (10): 1472–1477. PMID 8896687.
 | This sedative-related article is a stub. You can help Wikipedia by expanding it. |